0.5614
Schlusskurs vom Vortag:
$0.5601
Offen:
$0.5899
24-Stunden-Volumen:
46,180
Relative Volume:
0.15
Marktkapitalisierung:
$1.54M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-2.86M
KGV:
-0.2239
EPS:
-2.5071
Netto-Cashflow:
$-2.57M
1W Leistung:
+0.25%
1M Leistung:
-40.83%
6M Leistung:
-54.77%
1J Leistung:
-74.33%
Bone Biologics Corp Stock (BBLG) Company Profile
Firmenname
Bone Biologics Corp
Sektor
Branche
Telefon
(781) 552-4452
Adresse
2 BURLINGTON WOODS DRIVE,, BURLINGTON
Compare BBLG vs VRTX, REGN, ARGX, MRNA, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
BBLG
Bone Biologics Corp
|
0.5601 | 1.54M | 0 | -2.86M | -2.57M | -2.5071 |
|
VRTX
Vertex Pharmaceuticals Inc
|
522.72 | 134.06B | 12.34B | 4.34B | 3.71B | 16.87 |
|
REGN
Regeneron Pharmaceuticals Inc
|
804.34 | 83.43B | 14.92B | 4.42B | 3.79B | 41.04 |
|
ARGX
Argen X Se Adr
|
1,003.96 | 63.00B | 4.16B | 1.29B | 734.26M | 19.58 |
|
MRNA
Moderna Inc
|
137.64 | 56.02B | 2.23B | -3.19B | -1.60B | -8.1462 |
|
RVMD
Revolution Medicines Inc
|
209.05 | 44.44B | 742.00K | -1.37B | -1.07B | -7.0731 |
Bone Biologics Corp Aktie (BBLG) Neueste Nachrichten
Bone Biologics expands Australian trial to six hospital sites - Investing.com
Bone Biologics expands Australian trial to six hospital sites By Investing.com - Investing.com UK
Six Australian hospitals agree to join Bone Biologics' bone-graft trial - Stock Titan
A company developing bone products will meet investors in New York - Stock Titan
Bone Biologics (NASDAQ: BBLGW) Schedules Six Key Proposals for September 28 Shareholder Vote - Kalkine Media
Bone Biologics Corp Warrants (BBLGW) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Bone Biologics Corp Warrants (BBLGW) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Orthobiologics Market Report Examines Leading Companies And Growth Opportunities - openPR.com
Bone Biologics (NASDAQ:BSPK): What Could Its Scheduled Update Reveal? - Kalkine Media
Bone (BBLG): Finishes 3.47% Higher at $0.63 in Latest Trading; Current Setup: the Price Remains Bounded by the Supplied Support and Resistance for the Current SessionETF Outflow Streak - vinanet.vn
Bone (BBLGW): Shows Minimal Net Change at $8.24 in Latest Trading; Chart Watch: the Supplied Trading Band Runs From $7.83 to $8.65 under the Current SnapshotPut Flow Alert - siam.in
Bone (BBLG) Chart: Finishes 3.47% Lower at $0.62 for the Current Session; the Price Remains Bounded by the Supplied Support and Resistance under the Current SnapshotVolume Climax - vinanet.vn
Bone (BBLG) Results and Estimates: The Bottom-Line Figure Outpaces Its Comparison in the Current Update; Post-Report Move: The Stock Ends Down 2.58% in the Latest SessionEPS Growth Report - vinanet.vn
Bone Biologics (NASDAQ: BBLG) seeks 1-for-2 to 1-for-10 reverse split approval - Stock Titan
Price to sales forward of Bone Biologics Corp – NASDAQ:BBLGW - TradingView
Number of shareholders of Bone Biologics Corp – NASDAQ:BBLGW - tradingview.com
Bone Biologics Corp (BBLG) Slips 2.86% as Shares Test Key Support at $0.63Systematic Flow - vinanet.vn
BBLGW Warrants Hold Flat at $7.05 as Bone Biologics Consolidates Between $6.7 and $7.4Volatility Breakout Picks - vinanet.vn
Bone Biologics Raises $2.7M, Extends Cash Runway to Q2 2027 - Minichart
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Bone Biologics Warrants (BBLGW) Hold at $3.50 as Traders Eye Tight RangeEquity Put Call - dars.gov.et
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Bone Biologics Extends rhNELL-1 Validated Shelf Life to 32 Months as NB1 Study Advances - Yahoo Finance
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Bone Biologics Corporation Achieves 32-Month Validated Shelf Life For rhNELL-1 - marketscreener.com
Bone Biologics Achieves 32-Month Validated Shelf Life for rhNELL-1 - Stock Titan
Bone Biologics Corp expected to post a loss of 39 cents a shareEarnings Preview - TradingView
BBLG Q1 2026 Earnings: Narrower-Than-Expected Loss of -$0.43, Though Shares Slip 5.67%Performance Review - vinanet.vn
Bone Biologics Corp (BBLG) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
US: Halma sells NovaBone to Keensight-backed Isto Biologics for US$60m - Investors in Healthcare
Isto Biologics strengthens its bone graft substitutes platform with the acquisition of NovaBone - Ortho Spine News
Isto Biologics Acquires NovaBone | Press Release - ACCESS Newswire
Bone Biologics Warrants (BBLGW) Hold Flat at $8.00 as Range-Bound Trading PersistsMA Cross Alert - dars.gov.et
Bone Biologics (BBLG) Dips 3.23% to $0.85 — Shares Approach Key Support at $0.81Money Flow - vinanet.vn
Bone Biologics Corp Warrants (BBLGW) Hold Steady at $8.0 Amid Low Volume ConsolidationSell Signal Alerts - vinanet.vn
Bone Biologics Corp (BBLG) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Bone Biologics Corp Warrants (BBLGW) Holds Steady at $8.0 as Consolidation Pattern EmergesMESA MA - po-news-eg.net
Bone Biologics Corp (BBLG) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Bone Biologics Corp SEC Filing (Jul 27, 2026) - Stock Titan
Bone Biologics Corp (BBLG) Cash Flow - TradingKey
Bone Biologics Corp (BBLG) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Bone Biologics Corp (BBLG) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
BBLG|Bone Biologics Corp|Price:1.070|Chg%:-0.010 - TradingKey
BBLG|Bone Biologics Corp|Price:1.010|Chg%:-0.060 - TradingKey
Bone Biologics Corp (BBLG) Nears Support as Selling Pressure PersistsFactor Timing - vinanet.vn
Bone Biologics Corp Revenue Breakdown – NASDAQ:BBLGW - tradingview.com
TradingKey - TradingKey
BBLG Q1 2026 Earnings: Narrowed Loss Beats Estimates, But Stock DeclinesProfit Cycle Analysis - Vinanet
Bone Biologics Corp Revenue Breakdown – NASDAQ:BBLG - TradingView
Bone Biologics Corp (BBLG) Valuation: PE, PB & Fair Value Analysis - TradingKey
Bone Biologics raises $3.0M in July financing, extends rhNELL-1 shelf life to 29 months - TradingView
Finanzdaten der Bone Biologics Corp-Aktie (BBLG)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):